Based on the expression pattern of dystrophin by quantitative method, the patients were classified into two groups: group 1 - DMD patients with the absence of dystrophin (30 cases), group 2 - BMD patients with dystrophin deficiency (10 cases). This evidence concerns the gene DMD and Duchenne muscular dystrophy.